nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—asthma—chronic obstructive pulmonary disease	0.326	1	CtDrD
Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.146	0.506	CrCtD
Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.143	0.494	CrCtD
Ciclesonide—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.0438	0.307	CbGbCtD
Ciclesonide—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.143	CbGbCtD
Ciclesonide—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0194	0.135	CbGbCtD
Ciclesonide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0101	0.0707	CbGbCtD
Ciclesonide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0101	0.0707	CbGbCtD
Ciclesonide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00901	0.063	CbGbCtD
Ciclesonide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00848	0.0593	CbGbCtD
Ciclesonide—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.0068	0.0364	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.00652	0.0349	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.00636	0.0341	CrCrCtD
Ciclesonide—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.00613	0.0328	CrCrCtD
Ciclesonide—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00613	0.0328	CrCrCtD
Ciclesonide—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00598	0.0321	CrCrCtD
Ciclesonide—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00598	0.0321	CrCrCtD
Ciclesonide—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00598	0.0321	CrCrCtD
Ciclesonide—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00595	0.0319	CrCrCtD
Ciclesonide—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00581	0.0311	CrCrCtD
Ciclesonide—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00579	0.031	CrCrCtD
Ciclesonide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00573	0.0401	CbGbCtD
Ciclesonide—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00565	0.0303	CrCrCtD
Ciclesonide—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00563	0.0302	CrCrCtD
Ciclesonide—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00563	0.0302	CrCrCtD
Ciclesonide—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.0055	0.0295	CrCrCtD
Ciclesonide—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.0055	0.0295	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00549	0.0294	CrCrCtD
Ciclesonide—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00549	0.0294	CrCrCtD
Ciclesonide—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00549	0.0294	CrCrCtD
Ciclesonide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00547	0.0382	CbGbCtD
Ciclesonide—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00536	0.0287	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00536	0.0287	CrCrCtD
Ciclesonide—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00536	0.0287	CrCrCtD
Ciclesonide—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00536	0.0287	CrCrCtD
Ciclesonide—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00535	0.0287	CrCrCtD
Ciclesonide—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00522	0.028	CrCrCtD
Ciclesonide—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.0051	0.0273	CrCrCtD
Ciclesonide—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00498	0.0267	CrCrCtD
Ciclesonide—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00497	0.0267	CrCrCtD
Ciclesonide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00487	0.0341	CbGbCtD
Ciclesonide—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00486	0.026	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00476	0.0255	CrCrCtD
Ciclesonide—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00466	0.025	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00465	0.0249	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00447	0.024	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00437	0.0234	CrCrCtD
Ciclesonide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00286	0.02	CbGbCtD
Ciclesonide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0027	0.0189	CbGbCtD
Ciclesonide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000233	0.0632	CbGpPWpGaD
Ciclesonide—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00427	CcSEcCtD
Ciclesonide—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.000213	0.00414	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000206	0.0559	CbGpPWpGaD
Ciclesonide—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.000204	0.00397	CcSEcCtD
Ciclesonide—Osteoporosis—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00387	CcSEcCtD
Ciclesonide—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00382	CcSEcCtD
Ciclesonide—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00382	CcSEcCtD
Ciclesonide—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00381	CcSEcCtD
Ciclesonide—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00367	CcSEcCtD
Ciclesonide—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00364	CcSEcCtD
Ciclesonide—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.0036	CcSEcCtD
Ciclesonide—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00358	CcSEcCtD
Ciclesonide—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000184	0.00358	CcSEcCtD
Ciclesonide—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000184	0.00357	CcSEcCtD
Ciclesonide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000174	0.00338	CcSEcCtD
Ciclesonide—Ear pain—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00334	CcSEcCtD
Ciclesonide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.000172	0.00334	CcSEcCtD
Ciclesonide—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00328	CcSEcCtD
Ciclesonide—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00328	CcSEcCtD
Ciclesonide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000168	0.0457	CbGpPWpGaD
Ciclesonide—Ear pain—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00322	CcSEcCtD
Ciclesonide—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00321	CcSEcCtD
Ciclesonide—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00319	CcSEcCtD
Ciclesonide—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00319	CcSEcCtD
Ciclesonide—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00316	CcSEcCtD
Ciclesonide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000162	0.00315	CcSEcCtD
Ciclesonide—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0031	CcSEcCtD
Ciclesonide—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000157	0.00305	CcSEcCtD
Ciclesonide—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00301	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00289	CcSEcCtD
Ciclesonide—Osteoporosis—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00281	CcSEcCtD
Ciclesonide—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000144	0.0028	CcSEcCtD
Ciclesonide—Fracture—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00271	CcSEcCtD
Ciclesonide—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00271	CcSEcCtD
Ciclesonide—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.0027	CcSEcCtD
Ciclesonide—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.00262	CcSEcCtD
Ciclesonide—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.0026	CcSEcCtD
Ciclesonide—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.0026	CcSEcCtD
Ciclesonide—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000134	0.0026	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000132	0.00257	CcSEcCtD
Ciclesonide—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00255	CcSEcCtD
Ciclesonide—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00251	CcSEcCtD
Ciclesonide—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00251	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00251	CcSEcCtD
Ciclesonide—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.0025	CcSEcCtD
Ciclesonide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000127	0.00248	CcSEcCtD
Ciclesonide—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.00247	CcSEcCtD
Ciclesonide—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00247	CcSEcCtD
Ciclesonide—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00247	CcSEcCtD
Ciclesonide—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00246	CcSEcCtD
Ciclesonide—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00246	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000125	0.00243	CcSEcCtD
Ciclesonide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000125	0.00243	CcSEcCtD
Ciclesonide—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00242	CcSEcCtD
Ciclesonide—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00242	CcSEcCtD
Ciclesonide—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00237	CcSEcCtD
Ciclesonide—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00237	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00234	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00234	CcSEcCtD
Ciclesonide—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00233	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00229	CcSEcCtD
Ciclesonide—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00228	CcSEcCtD
Ciclesonide—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00225	CcSEcCtD
Ciclesonide—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.00225	CcSEcCtD
Ciclesonide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000115	0.00224	CcSEcCtD
Ciclesonide—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00221	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00221	CcSEcCtD
Ciclesonide—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00219	CcSEcCtD
Ciclesonide—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00219	CcSEcCtD
Ciclesonide—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00218	CcSEcCtD
Ciclesonide—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00218	CcSEcCtD
Ciclesonide—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00218	CcSEcCtD
Ciclesonide—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00218	CcSEcCtD
Ciclesonide—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00213	CcSEcCtD
Ciclesonide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000108	0.0021	CcSEcCtD
Ciclesonide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.0021	CcSEcCtD
Ciclesonide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.0021	CcSEcCtD
Ciclesonide—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00207	CcSEcCtD
Ciclesonide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00206	CcSEcCtD
Ciclesonide—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00206	CcSEcCtD
Ciclesonide—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00206	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000105	0.0285	CbGpPWpGaD
Ciclesonide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.00203	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000104	0.0283	CbGpPWpGaD
Ciclesonide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000104	0.00202	CcSEcCtD
Ciclesonide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00202	CcSEcCtD
Ciclesonide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00202	CcSEcCtD
Ciclesonide—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000103	0.002	CcSEcCtD
Ciclesonide—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.002	CcSEcCtD
Ciclesonide—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.002	CcSEcCtD
Ciclesonide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00198	CcSEcCtD
Ciclesonide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.00198	CcSEcCtD
Ciclesonide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00198	CcSEcCtD
Ciclesonide—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00196	CcSEcCtD
Ciclesonide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	9.86e-05	0.00192	CcSEcCtD
Ciclesonide—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	9.81e-05	0.00191	CcSEcCtD
Ciclesonide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	9.79e-05	0.0019	CcSEcCtD
Ciclesonide—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	9.76e-05	0.0019	CcSEcCtD
Ciclesonide—Cough—Tiotropium—chronic obstructive pulmonary disease	9.73e-05	0.00189	CcSEcCtD
Ciclesonide—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	9.69e-05	0.00189	CcSEcCtD
Ciclesonide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	9.63e-05	0.00187	CcSEcCtD
Ciclesonide—Infection—Aminophylline—chronic obstructive pulmonary disease	9.59e-05	0.00187	CcSEcCtD
Ciclesonide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	9.57e-05	0.00186	CcSEcCtD
Ciclesonide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	9.5e-05	0.00185	CcSEcCtD
Ciclesonide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	9.5e-05	0.00185	CcSEcCtD
Ciclesonide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	9.34e-05	0.00182	CcSEcCtD
Ciclesonide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	9.34e-05	0.00182	CcSEcCtD
Ciclesonide—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.32e-05	0.00181	CcSEcCtD
Ciclesonide—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	9.32e-05	0.00181	CcSEcCtD
Ciclesonide—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.00181	CcSEcCtD
Ciclesonide—Contusion—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00181	CcSEcCtD
Ciclesonide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	9.29e-05	0.00181	CcSEcCtD
Ciclesonide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	9.15e-05	0.00178	CcSEcCtD
Ciclesonide—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	9.13e-05	0.00178	CcSEcCtD
Ciclesonide—Rash—Roflumilast—chronic obstructive pulmonary disease	9.13e-05	0.00178	CcSEcCtD
Ciclesonide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	9.12e-05	0.00177	CcSEcCtD
Ciclesonide—Headache—Roflumilast—chronic obstructive pulmonary disease	9.07e-05	0.00176	CcSEcCtD
Ciclesonide—Infection—Tiotropium—chronic obstructive pulmonary disease	9.04e-05	0.00176	CcSEcCtD
Ciclesonide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	8.82e-05	0.00172	CcSEcCtD
Ciclesonide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	8.81e-05	0.00171	CcSEcCtD
Ciclesonide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	8.81e-05	0.00171	CcSEcCtD
Ciclesonide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.8e-05	0.00171	CcSEcCtD
Ciclesonide—Back pain—Arformoterol—chronic obstructive pulmonary disease	8.71e-05	0.00169	CcSEcCtD
Ciclesonide—Back pain—Formoterol—chronic obstructive pulmonary disease	8.71e-05	0.00169	CcSEcCtD
Ciclesonide—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	8.68e-05	0.423	CrCbGaD
Ciclesonide—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.6e-05	0.00167	CcSEcCtD
Ciclesonide—Ulcer—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.00167	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	8.54e-05	0.0232	CbGpPWpGaD
Ciclesonide—Cataract—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.00166	CcSEcCtD
Ciclesonide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	8.5e-05	0.00165	CcSEcCtD
Ciclesonide—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	8.37e-05	0.408	CrCbGaD
Ciclesonide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.00162	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.29e-05	0.00161	CcSEcCtD
Ciclesonide—Angioedema—Formoterol—chronic obstructive pulmonary disease	8.22e-05	0.0016	CcSEcCtD
Ciclesonide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	8.22e-05	0.0016	CcSEcCtD
Ciclesonide—Back pain—Salbutamol—chronic obstructive pulmonary disease	8.22e-05	0.0016	CcSEcCtD
Ciclesonide—Angioedema—Montelukast—chronic obstructive pulmonary disease	8.06e-05	0.00157	CcSEcCtD
Ciclesonide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	8.01e-05	0.00156	CcSEcCtD
Ciclesonide—Palpitations—Formoterol—chronic obstructive pulmonary disease	7.95e-05	0.00155	CcSEcCtD
Ciclesonide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	7.95e-05	0.00155	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	7.86e-05	0.00153	CcSEcCtD
Ciclesonide—Cough—Arformoterol—chronic obstructive pulmonary disease	7.85e-05	0.00153	CcSEcCtD
Ciclesonide—Cough—Formoterol—chronic obstructive pulmonary disease	7.85e-05	0.00153	CcSEcCtD
Ciclesonide—Palpitations—Montelukast—chronic obstructive pulmonary disease	7.79e-05	0.00152	CcSEcCtD
Ciclesonide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	7.77e-05	0.00151	CcSEcCtD
Ciclesonide—Hypertension—Formoterol—chronic obstructive pulmonary disease	7.77e-05	0.00151	CcSEcCtD
Ciclesonide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	7.77e-05	0.00151	CcSEcCtD
Ciclesonide—Cough—Montelukast—chronic obstructive pulmonary disease	7.69e-05	0.0015	CcSEcCtD
Ciclesonide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	7.67e-05	0.00149	CcSEcCtD
Ciclesonide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	7.66e-05	0.00149	CcSEcCtD
Ciclesonide—Chest pain—Formoterol—chronic obstructive pulmonary disease	7.66e-05	0.00149	CcSEcCtD
Ciclesonide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	7.66e-05	0.00149	CcSEcCtD
Ciclesonide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	7.66e-05	0.00149	CcSEcCtD
Ciclesonide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	7.51e-05	0.00146	CcSEcCtD
Ciclesonide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	7.51e-05	0.00146	CcSEcCtD
Ciclesonide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	7.49e-05	0.00146	CcSEcCtD
Ciclesonide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	7.49e-05	0.00146	CcSEcCtD
Ciclesonide—Cough—Salbutamol—chronic obstructive pulmonary disease	7.42e-05	0.00144	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	7.41e-05	0.0201	CbGpPWpGaD
Ciclesonide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	7.34e-05	0.00143	CcSEcCtD
Ciclesonide—Infection—Formoterol—chronic obstructive pulmonary disease	7.3e-05	0.00142	CcSEcCtD
Ciclesonide—Infection—Arformoterol—chronic obstructive pulmonary disease	7.3e-05	0.00142	CcSEcCtD
Ciclesonide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	7.24e-05	0.00141	CcSEcCtD
Ciclesonide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	7.24e-05	0.00141	CcSEcCtD
Ciclesonide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	7.23e-05	0.00141	CcSEcCtD
Ciclesonide—Infection—Montelukast—chronic obstructive pulmonary disease	7.15e-05	0.00139	CcSEcCtD
Ciclesonide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	7.08e-05	0.00138	CcSEcCtD
Ciclesonide—Infection—Salbutamol—chronic obstructive pulmonary disease	6.89e-05	0.00134	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	6.78e-05	0.0184	CbGpPWpGaD
Ciclesonide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.00132	CcSEcCtD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	6.74e-05	0.0183	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.69e-05	0.0013	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.69e-05	0.0013	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.56e-05	0.00128	CcSEcCtD
Ciclesonide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	6.55e-05	0.00127	CcSEcCtD
Ciclesonide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	6.55e-05	0.00127	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	6.55e-05	0.0178	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	6.51e-05	0.0177	CbGpPWpGaD
Ciclesonide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.47e-05	0.00126	CcSEcCtD
Ciclesonide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.47e-05	0.00126	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	6.43e-05	0.0175	CbGpPWpGaD
Ciclesonide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.38e-05	0.00124	CcSEcCtD
Ciclesonide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	6.37e-05	0.00124	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	6.35e-05	0.0172	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.34e-05	0.00123	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.34e-05	0.00123	CcSEcCtD
Ciclesonide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.33e-05	0.00123	CcSEcCtD
Ciclesonide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.33e-05	0.00123	CcSEcCtD
Ciclesonide—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.33e-05	0.00123	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.32e-05	0.00123	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	6.3e-05	0.0171	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.21e-05	0.00121	CcSEcCtD
Ciclesonide—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.2e-05	0.00121	CcSEcCtD
Ciclesonide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.18e-05	0.0012	CcSEcCtD
Ciclesonide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	6.11e-05	0.00119	CcSEcCtD
Ciclesonide—Rash—Aminophylline—chronic obstructive pulmonary disease	6.09e-05	0.00118	CcSEcCtD
Ciclesonide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.08e-05	0.00118	CcSEcCtD
Ciclesonide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	6.06e-05	0.00118	CcSEcCtD
Ciclesonide—Headache—Aminophylline—chronic obstructive pulmonary disease	6.05e-05	0.00118	CcSEcCtD
Ciclesonide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.02e-05	0.00117	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.99e-05	0.00117	CcSEcCtD
Ciclesonide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.98e-05	0.00116	CcSEcCtD
Ciclesonide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	5.84e-05	0.00114	CcSEcCtD
Ciclesonide—Urticaria—Formoterol—chronic obstructive pulmonary disease	5.84e-05	0.00114	CcSEcCtD
Ciclesonide—Rash—Tiotropium—chronic obstructive pulmonary disease	5.74e-05	0.00112	CcSEcCtD
Ciclesonide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.73e-05	0.00112	CcSEcCtD
Ciclesonide—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.73e-05	0.00112	CcSEcCtD
Ciclesonide—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.72e-05	0.00111	CcSEcCtD
Ciclesonide—Headache—Tiotropium—chronic obstructive pulmonary disease	5.7e-05	0.00111	CcSEcCtD
Ciclesonide—Face oedema—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.0011	CcSEcCtD
Ciclesonide—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	5.64e-05	0.0153	CbGpPWpGaD
Ciclesonide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	5.63e-05	0.00109	CcSEcCtD
Ciclesonide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	5.6e-05	0.00109	CcSEcCtD
Ciclesonide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.51e-05	0.00107	CcSEcCtD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	5.43e-05	0.0147	CbGpPWpGaD
Ciclesonide—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.41e-05	0.00105	CcSEcCtD
Ciclesonide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.27e-05	0.00103	CcSEcCtD
Ciclesonide—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.27e-05	0.00103	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.00101	CcSEcCtD
Ciclesonide—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.16e-05	0.001	CcSEcCtD
Ciclesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.0138	CbGpPWpGaD
Ciclesonide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.98e-05	0.000968	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	4.91e-05	0.0133	CbGpPWpGaD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	4.9e-05	0.0133	CbGpPWpGaD
Ciclesonide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.86e-05	0.000945	CcSEcCtD
Ciclesonide—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.86e-05	0.000945	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	4.82e-05	0.0131	CbGpPWpGaD
Ciclesonide—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.76e-05	0.000926	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	4.75e-05	0.0129	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	4.69e-05	0.0127	CbGpPWpGaD
Ciclesonide—Rash—Arformoterol—chronic obstructive pulmonary disease	4.63e-05	0.000901	CcSEcCtD
Ciclesonide—Rash—Formoterol—chronic obstructive pulmonary disease	4.63e-05	0.000901	CcSEcCtD
Ciclesonide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.63e-05	0.0009	CcSEcCtD
Ciclesonide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.63e-05	0.0009	CcSEcCtD
Ciclesonide—Weight increased—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.0009	CcSEcCtD
Ciclesonide—Headache—Arformoterol—chronic obstructive pulmonary disease	4.6e-05	0.000895	CcSEcCtD
Ciclesonide—Headache—Formoterol—chronic obstructive pulmonary disease	4.6e-05	0.000895	CcSEcCtD
Ciclesonide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.59e-05	0.000892	CcSEcCtD
Ciclesonide—Rash—Montelukast—chronic obstructive pulmonary disease	4.54e-05	0.000883	CcSEcCtD
Ciclesonide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.53e-05	0.000882	CcSEcCtD
Ciclesonide—Headache—Montelukast—chronic obstructive pulmonary disease	4.51e-05	0.000877	CcSEcCtD
Ciclesonide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.45e-05	0.000867	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	4.42e-05	0.012	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	4.41e-05	0.012	CbGpPWpGaD
Ciclesonide—Rash—Salbutamol—chronic obstructive pulmonary disease	4.37e-05	0.000851	CcSEcCtD
Ciclesonide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.37e-05	0.00085	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	4.37e-05	0.0119	CbGpPWpGaD
Ciclesonide—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.36e-05	0.000849	CcSEcCtD
Ciclesonide—Nausea—Formoterol—chronic obstructive pulmonary disease	4.36e-05	0.000849	CcSEcCtD
Ciclesonide—Headache—Salbutamol—chronic obstructive pulmonary disease	4.35e-05	0.000845	CcSEcCtD
Ciclesonide—Nausea—Montelukast—chronic obstructive pulmonary disease	4.27e-05	0.000831	CcSEcCtD
Ciclesonide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.21e-05	0.000819	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.0114	CbGpPWpGaD
Ciclesonide—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.12e-05	0.000802	CcSEcCtD
Ciclesonide—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.0111	CbGpPWpGaD
Ciclesonide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.09e-05	0.000796	CcSEcCtD
Ciclesonide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000792	CcSEcCtD
Ciclesonide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	4.01e-05	0.0109	CbGpPWpGaD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.94e-05	0.0107	CbGpPWpGaD
Ciclesonide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	3.84e-05	0.0104	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.01	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	3.68e-05	0.01	CbGpPWpGaD
Ciclesonide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.68e-05	0.000715	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	3.65e-05	0.0099	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.00964	CbGpPWpGaD
Ciclesonide—Prednisone—ALB—chronic obstructive pulmonary disease	3.45e-05	0.168	CrCbGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	3.37e-05	0.00916	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	3.25e-05	0.00883	CbGpPWpGaD
Ciclesonide—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.00063	CcSEcCtD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	3.2e-05	0.0087	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	3.17e-05	0.00862	CbGpPWpGaD
Ciclesonide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.16e-05	0.000615	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.14e-05	0.00852	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.08e-05	0.00836	CbGpPWpGaD
Ciclesonide—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.06e-05	0.000595	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.00827	CbGpPWpGaD
Ciclesonide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000587	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.01e-05	0.00818	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	2.93e-05	0.00796	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.00792	CbGpPWpGaD
Ciclesonide—Infection—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000559	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.79e-05	0.00758	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.00728	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.67e-05	0.00724	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.64e-05	0.00717	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.63e-05	0.000512	CcSEcCtD
Ciclesonide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.63e-05	0.000512	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.62e-05	0.00711	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.007	CbGpPWpGaD
Ciclesonide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.000495	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.53e-05	0.00688	CbGpPWpGaD
Ciclesonide—Rash—Prednisolone—chronic obstructive pulmonary disease	2.51e-05	0.000488	CcSEcCtD
Ciclesonide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.51e-05	0.000488	CcSEcCtD
Ciclesonide—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000485	CcSEcCtD
Ciclesonide—Headache—Prednisolone—chronic obstructive pulmonary disease	2.49e-05	0.000485	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.45e-05	0.00667	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.43e-05	0.0066	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	2.41e-05	0.00655	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.4e-05	0.00651	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.38e-05	0.00647	CbGpPWpGaD
Ciclesonide—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.36e-05	0.00046	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.35e-05	0.00638	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.34e-05	0.00636	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.00628	CbGpPWpGaD
Ciclesonide—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.3e-05	0.000447	CcSEcCtD
Ciclesonide—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.07e-05	0.000404	CcSEcCtD
Ciclesonide—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.91e-05	0.000372	CcSEcCtD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.00516	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.00515	CbGpPWpGaD
Ciclesonide—Rash—Prednisone—chronic obstructive pulmonary disease	1.82e-05	0.000355	CcSEcCtD
Ciclesonide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.82e-05	0.000354	CcSEcCtD
Ciclesonide—Headache—Prednisone—chronic obstructive pulmonary disease	1.81e-05	0.000352	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.00489	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	1.78e-05	0.00484	CbGpPWpGaD
Ciclesonide—Nausea—Prednisone—chronic obstructive pulmonary disease	1.72e-05	0.000334	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00466	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.00462	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.00456	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.65e-05	0.00449	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.57e-05	0.00427	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.57e-05	0.00426	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.55e-05	0.00421	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.00416	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.00411	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.51e-05	0.0041	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.46e-05	0.00397	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.00375	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.00374	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.31e-05	0.00355	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.00347	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.00337	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.23e-05	0.00335	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.0033	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.00326	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.00302	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.00298	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.05e-05	0.00286	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.00274	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.95e-06	0.0027	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	9.88e-06	0.00268	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	9.63e-06	0.00262	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	9.27e-06	0.00252	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.03e-06	0.00245	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.02e-06	0.00245	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.66e-06	0.00235	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	8.48e-06	0.0023	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.41e-06	0.00229	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.3e-06	0.00225	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.94e-06	0.00216	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.84e-06	0.00213	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	7.79e-06	0.00212	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.73e-06	0.0021	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.63e-06	0.00207	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.33e-06	0.00199	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.33e-06	0.00199	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	7.27e-06	0.00198	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.23e-06	0.00196	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.6e-06	0.00179	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.5e-06	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.28e-06	0.00171	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.9e-06	0.0016	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	5.87e-06	0.00159	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.5e-06	0.00149	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.43e-06	0.00147	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.07e-06	0.00138	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.06e-06	0.00137	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.99e-06	0.00135	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.79e-06	0.0013	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.76e-06	0.00129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.73e-06	0.00128	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.5e-06	0.00122	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.43e-06	0.0012	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.91e-06	0.00106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.86e-06	0.00105	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.8e-06	0.00103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.53e-06	0.00096	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.55e-06	0.000694	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.48e-06	0.000675	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.31e-06	0.000627	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.17e-06	0.000589	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.08e-06	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-06	0.000557	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-06	0.000509	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.73e-06	0.000469	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-06	0.000391	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-06	0.000385	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-06	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-06	0.000364	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-06	0.000359	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-06	0.000341	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-06	0.000333	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-06	0.000306	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.41e-07	0.000256	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.28e-07	0.000252	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.64e-07	0.000235	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.52e-07	0.000231	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.2e-07	0.000223	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.15e-07	0.000221	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.57e-07	0.000151	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.33e-07	0.000145	CbGpPWpGaD
